Cipla trades higher on the bourses

12 Jan 2016 Evaluate

Cipla is currently trading at Rs. 612.20, up by 1.95 points or 0.32% from its previous closing of Rs. 610.25 on the BSE.

The scrip opened at Rs. 609.80 and has touched a high and low of Rs. 618.00 and Rs. 605.75 respectively. So far 58157 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 752.45 on 10-Mar-2015 and a 52 week low of Rs. 572.00 on 15-Jun-2015.

Last one week high and low of the scrip stood at Rs. 657.60 and Rs. 604.55 respectively. The current market cap of the company is Rs. 49134.12 crore.

The promoters holding in the company stood at 36.79 % while Institutions and Non-Institutions held 34.24% and 26.63% respectively.

Cipla has entered into a strategic distribution, supply and development agreement with the US-based BioQ Pharma for registration and commercialisation of the latter’s Ropivacaine infusion system, used in treating post-operative pain, in India.

The Ropivacaine infusion system is pre-filled, ready to use at the point of care, and intended to provide a safer, more efficient continuous-infusion post-operative pain solution. BioQ Pharma’s unit-dose infusion pharmaceuticals have been developed as ready-to-use presentations in which the drugs and administration systems are self-contained and delivered at the point of care.

Cipla’s proven, hospital-focused sales and marketing organisation will be essential in introducing BioQ Pharma’s proprietary unit-dose, large volume infusion pharmaceuticals to India’s healthcare market.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×